Dr Reddys Laboratories Share Price Today - Live Blog for September 30, 2025

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.36% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,229.30 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd plunged by -0.02%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,222.70, but investors are assessing whether this is a temporary dip or a long-term trend.

Dr Reddys Laboratories Ltd shares saw a -0.20% decrease, reaching a current market price of ₹1,222.10. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 18.1500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.11%, and as of now, it's trading at ₹1,225.25 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd observed a remarkable 0.21% surge in its share price and is presently trading at ₹1,223.00. The increased investor interest is driving this surge.

After a notable 0.08% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,222.00. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd share price has declined by -0.22%, and it's currently trading at ₹1,221.00. The stock maintains a PE of 18.1500, while the industry PE is 33.8643, prompting discussions about its valuation.

The stock of Dr Reddys Laboratories Ltd suffered a -0.22% drop, and it's now trading at ₹1,221.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.05%, reaching the current market price of ₹1,222.60. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Demonstrating a commendable 0.05% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,222.60. In terms of valuation, the stock maintains a PE ratio of 18.1500, while the industry PE ratio stands at 33.8643.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.27% drop, and it's now trading at ₹1,228.20 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd experienced a -0.27% dip in its share price and is currently trading at ₹1,228.20. The stock has a PE ratio of 18.1500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd experienced a -0.29% slump and is currently trading at ₹1,232.35. While the stock maintains a PE ratio of 18.1500, the industry PE is 33.8643, raising questions about valuation.

Dr Reddys Laboratories Ltd's share price has dropped by -0.01%, a development that warrants careful analysis. Presently trading at ₹1,235.90, investors are assessing whether this presents an opportunity or a risk.

After a significant 0.11% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,237.05 in the current market. This upward movement is attracting attention from both retail and institutional investors.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.04% upswing and is currently trading at ₹1,234.80, indicating strong market sentiment.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.12% upswing, and it's currently trading at ₹1,235.65 per share. Investors are closely watching this development.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.30% in its share price, and it currently trades at ₹1,233.75 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price surged by 0.03%. With its current market price standing at ₹1,237.80 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.06% uptick in its share price. As a result, it's now actively trading at ₹1,235.80 per share, making it an attractive option for investors.

The stock of Dr Reddys Laboratories Ltd suffered a -0.04% drop, and it's now trading at ₹1,234.50 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd share price surged by 0.18%. With its current market price standing at ₹1,235.05 per share, this stock is garnering increased attention from the investment community.

The stock of Dr Reddys Laboratories Ltd suffered a -0.15% decline, and it currently trades at ₹1,233.20 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

With a -0.32% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,234.60. The stock is currently trading at a PE of 18.1500, while the industry PE is 33.8643, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd witnessed a notable 0.11% surge in its share price and is presently trading at ₹1,238.70, captivating the attention of market participants.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.12% increase and currently trading at ₹1,237.45 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd's shares experienced a 0.17% uptick, and they are currently valued at ₹1,236.90, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.04% increase and currently trading at ₹1,235.55 per share. This upward trajectory is turning heads in the market.